-
REAL-WORLD TREATMENT PATTERNS ACROSS FIRST-, SECOND- AND THIRD-LINE THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM DANISH NATIONAL REGISTER DATA
Aug 11, 2026, 17:16 PM -
A 10 YEAR RETROSPECTIVE REVIEW OF DOSE MODIFICATION OF INFLIXIMAB THERAPY IN PRIVATE HOSPITALS IN IRELAND
Aug 11, 2026, 17:16 PM -
KNOWING THE RULES: APPLICANT GUIDANCE AND PREDICTABILITY IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
FINANCING HIGH-COST RARE DISEASE MEDICINES IN LATIN AMERICA (LATAM): INNOVATIVE FUNDING AND ACCESS MECHANISMS ACROSS KEY MARKETS
Aug 11, 2026, 17:16 PM -
HIDDEN COSTS OF POST-MARKET MONITORING OF AI-ENABLED MEDICAL DEVICES: A SYSTEMATIC REVIEW TO INFORM HEALTH TECHNOLOGY ASSESSMENT FRAMEWORKS
Aug 11, 2026, 17:16 PM -
THE MEDIATING ROLE OF BODY IMAGE DISTORTION IN THE ASSOCIATION BETWEEN SMARTPHONE SCREEN TIME AND MENTAL HEALTH AMONG KOREAN ADOLESCENTS
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC BURDEN OF CHRONIC LYMPHOCYTIC LEUKEMIA IN 43 EUROPEAN COUNTRIES
Aug 11, 2026, 17:16 PM -
COMPARING ARTIFICIAL INTELLIGENCE SCREENING TOOLS IN HEALTH ECONOMIC SYSTEMATIC REVIEWS
Aug 11, 2026, 17:16 PM -
THE HIDDEN NUMERICAL ERRORS IN EXCEL AND WHAT THEY MEAN FOR VALIDATING R-BASED COST-EFFECTIVENESS MODELS USING EXCEL
Aug 11, 2026, 17:16 PM -
STRENGTHENING PATIENT VOICE IN HEALTH TECHNOLOGY ASSESSMENT VALUE JUDGEMENT ACROSS GULF COOPERATION COUNCIL HEALTH SYSTEMS
Aug 11, 2026, 17:16 PM -
FERROUS IRON FORMULATIONS IN GREECE, 2020-2025: IMPACT OF REIMBURSEMENT POLICIES, PRODUCT DELISTING, AND PRESCRIBING RESTRICTIONS ON UTILIZATION AND PHARMACEUTICAL EXPENDITURE
Aug 11, 2026, 17:16 PM -
BEYOND AVERAGE PREFERENCES: LATENT PREFERENCE CLASSES IN THE MULTIDIMENSIONAL VALUATION OF DIGITAL HEALTH INTERVENTIONS
Aug 11, 2026, 17:16 PM -
UNDERSTANDING THE SOCIAL VALUE MANUFACTURER REVENUE AND REINVESTMENT - A CASE STUDY USING PALBOCICLIB IN HR+/HER2- ADVANCED BREAST CANCER
Aug 11, 2026, 17:16 PM -
ANTICIPATING FUTURE EVIDENCE NEEDS IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): A LIVING EVIDENCE ANALYSIS FOR HTA, JCA, AND IRA DECISION-MAKING
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFECTIVENESS OF AFAMI-CEL IN SYNOVIAL SARCOMA USING UNANCHORED MATCHING-ADJUSTED INDIRECT COMPARISONS
Aug 11, 2026, 17:16 PM -
PROMS IN LONG-COVID AND ME/CFS/POST-VIRAL FATIGUE: ANALYSIS OF STUDY RECORDS FROM THE PAST 2 YEARS (2024-2026)
Aug 11, 2026, 17:16 PM -
FROM AMBIGUITY TO AGREEMENT: STRENGTHENING EDELPHI CONSENSUS THROUGH RIGOROUS SURVEY INSTRUMENT DESIGN
Aug 11, 2026, 17:16 PM -
A SYSTEMATIC LITERATURE REVIEW ON ECONOMIC EVIDENCE FOR CONTINUOUS POSITIVE AIRWAY PRESSURE ADHERENCE IN OBSTRUCTIVE SLEEP APNEA
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF SURROGATE ENDPOINTS IN EU4 + UK HTA DECISION-MAKING FOR ANTIBODY-DRUG CONJUGATES IN BREAST CANCER
Aug 11, 2026, 17:16 PM -
RARE BUT COSTLY: PREVALENCE AND DIRECT MEDICAL COSTS OF 15 RARE DISEASES AMONG DAMAN BENEFICIARIES IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM
